Slider background

Fidelta is now part
of Selvita Group

Together we can support your projects
in an even more integrated way!

Find out more

Welcome to Fidelta

Excellence in integrated drug discovery services

Are you looking for the partner who can take your project from target to preclinical development?

Fidelta has the necessary set up and expertise for fully integrated drug discovery, backed up by a successful delivery track record.

Our goal is to provide efficacious, safe and differentiated preclinical candidates. We place strong emphasis on translational science, focusing on disease relevant animal models and ex-vivo studies where appropriate from patient samples, with the discovery process driven by expert medicinal chemistry and ADME/PK.

Go to About Us

News & Events

Ardigen webinar – “AI methods in small molecule design.”
02 June 2021

Ardigen webinar – “AI methods in small molecule design.”

Selvita Group reports over a two-fold increase in revenues for Q1 2021
26 May 2021

Selvita Group reports over a two-fold increase in revenues for Q1 2021

Fidelta Webinar – “Immunopathology and preclinical modelling of systemic lupus erythematosus (SLE)”
24 May 2021

Fidelta Webinar – “Immunopathology and preclinical modelling of systemic lupus erythematosus (SLE)”